Recombinant SNAP-25 is an effective substrate for Clostridium botulinum type A toxin endopeptidase activity in vitro

Microbiology

Volumn 143, Issue 10, 1997, Pages 3337-3347

  Ekong, Theresa A N ^a   Feavers, Ian M ^a   Sesardic, Dorothea ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Botulinum neurotoxin type A; Endopeptidase assay; Recombinant SNAP 25; Targeted antibodies

Indexed keywords

ANTIBODY; BLOOD CLOTTING FACTOR 10A; BOTULINUM TOXIN A; HYBRID PROTEIN; MALTOSE BINDING PROTEIN; PROTEINASE; RECOMBINANT DNA; RECOMBINANT PROTEIN;

AFFINITY CHROMATOGRAPHY; ANIMAL TISSUE; ARTICLE; CLOSTRIDIUM BOTULINUM; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; ESCHERICHIA COLI; IMMUNOASSAY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PURIFICATION; RAT; RECOMBINANT DNA TECHNOLOGY;

ANIMALIA; BACTERIA (MICROORGANISMS); CLOSTRIDIUM BOTULINUM; ESCHERICHIA COLI;

EID: 0030782182     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/00221287-143-10-3337     Document Type: Article

References (41)

1. Balls, M. & Straughan, D. W. (1996). The three R's of Russell & Burch and the testing of biological products. Dev Biol Stand 86, 8-11.
2. Binz, T., Blasi, J., Yamasaki, S., Baumeister, A., Link, E., Sudhof, T. C., Jahn, R. & Niemann, H. (1994). Proteolysis of SNAP-25 by types A and E botulinal neurotoxins. J Biol Chem 269, 1617-1620.
3. Blasi, J., Chapman, E. R., Link, E., Binz, T., Yamasaki, S., De Camilli, P., Südhof, T. C., Niemann, H. & Jahn, R. (1993). Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365, 160-163.
4. Doellgast, G. J., Triscott, M. X., Beard, A. G., Bottoms, J. D., Cheng, T., Roh, B. H., Roman, M. G., Hall, P. A. & Brown, J. E. (1993). Sensitive enzyme-linked immunosorbent assay for detection of Clostridium botulinum neurotoxins A, B and E using signal amplification via enzyme-linked coagulation assay. J Clin Microbiol 31, 2402-2409.
5. Ekong, T. A. N., McLellan, K. & Sesardic, D. (1995). Immunological detection of Clostridium botulinum toxin type A in therapeutic preparations. J Immunol Methods 180, 181-191.
6. Ekong, T. A. N., Gee, C., Blasi, J. & Sesardic, D. (1997). An alternative bioassay for botulinum neurotoxin type A based on its endopeptidase activity. Dev Anim Vet Sci 27, 1039-1045.
7. Ferrer-Montiel, A. V., Canaves, J. M., DasGupta, B. R., Wilson, M. C. & Montal, M. (1996). Tyrosine phosphorylation modulates the activity of clostridia neurotoxins. J Biol Chem 271, 18322-18325.
8. Foran, P., Shone, C. C. & Dolly, J. O. (1994). Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments. Biochemistry 33, 15365-15374.
9. Foran, P., Lawrence, G. W., Shone, C. C., Foster, K. A. & Dolly, J. O. (1996). Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilised chromaffin cells: correlation with its blockade of catecholamine release. Biochemistry 35, 2630-2636.
10. Fukuoka, Y., Tachibana, T. & Yasui, A. (1993). Expression of biologically active C3a as fusion proteins. Immunol Lett 38, 153-158.
11. Hallis, B., James, B. A. F. & Shone, C. C. (1996). Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activity. J Clin Microbiol 34, 1934-1938.
12. Huttner, W. B., Schiebler, W., Greengard, P. & de Camilli, P. (1983). Synapsin I (Protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in highly purified synaptic vesicle preparation. J Biol Chem 96, 1374-1388.
13. Jankovic, J. & Brin, M. F. (1991). Therapeutic uses of botulinum neurotoxin. N Engl J Med 324, 1186-1194.
14. Kumar, P., Colston, J. T., Chambers, J. P., Rael, E. P. & Valdes, J. J. (1994). Detection of botulinum toxin using an evanescent wave immunosensor. Biosens Bioelectronics 9, 57-63.
15. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
16. Li, Y., Foran, P., Fairweather, N. F., de Paiva, A., Weller, U., Dougan, G. & Dolly, J. O. (1994). A single mutation in the recombinant light chain of tetanus toxin abolishes its proteolytic activity and removes the toxicity seen after reconstitution with native heavy chain. Biochemistry 33, 7014-7020.
17. Link, E., Edelmann, L., Chou, J. H., Binz, T., Yamasaki, S., Eisel, U., Baumert, M., Sudhof, T. C., Niemann, H. & Jahn, R. (1992). Tetanus toxin action: inhibition of neurotransmitter release linked to synaptobrevin proteolysis. Biochem Biophys Res Commun 189, 1017-1023.
18. McLellan, K., Gaines Das, G. E., Ekong, T. A. N. & Sesardic, D. (1996). Therapeutic botulinum type A toxin: factors affecting potency. Toxicon 34, 975-985.
19. Montecucco, C. & Schiavo, G. (1993). Tetanus and botulinum neurotoxins: a new family of metalloproteases. Trends Biochem Sci 18, 324-327.
20. Montecucco, C. & Schiavo, G. (1995). The structure and function of tetanus and botulinum neurotoxins. Q Rev Biophys 28, 423-472.
21. Neu, H. C. & Heppel, L. A. (1965). The release of enzymes from Escherichia coli by osmotic shock and during the formation of spheroplasts. J Biol Chem 240, 3685-3692.
22. Niemann, H., Hayashi, T., Yamasaki, S., Neuenberg, P., Mannìer, P. & Binz, T. (1996). Toxins and substrates: structural requirements for formation of protein/substrate complexes. In Abstracts of the International Conference for Biomedical Aspects of Clostridial Neurotoxins, Oxford, UK, 1996, Abstract 16.
23. Oyler, G. A., Higgins, G. A., Hart, R. A., Battenberg, E., Billinsgley, M., Bloom, F. E. & Wilson, M. C. (1989). The identification of a novel synaptosomal-associated protein, SNAP-25, differentially expressed by neuronal subpopulations. J Biol Chem 109, 3039-3052.
24. Pearce, L. B., Borodic, G. E., Johnson, E. A., First, E. R. & MacCallum, R. D. (1995). The median paralysis unit: a more pharmacologically relevant unit of biologic activity for botulinum toxin. Toxicon 33, 217-227.
25. Rossetto, O., Schiavo, G., Montecucco, C., Poulain, B., Deloye, F., Lozzi, L. & Shone, C. C. (1994). SNARE motif and neurotoxins. Nature 372, 415-416.
26. Sakaguchi, G. (1983). Clostridium botulinum toxins. Pharmacol Ther 19, 165-194.
27. Schantz, E. J. & Johnson, E. A. (1992). Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol Rev 56, 80-99.
28. Schiavo, G., Benfenati, F., Poulain, B., Rossetto, O., de Laureto, P. P., DasGupta, B. R. & Montecucco, C. (1992). Tetanus and botulinum B neurotoxins block transmitter release by proteolytic cleavage of synaptobrevin. Nature 359, 832-835.
29. Schiavo, G., Santucci, A., DasGupta, B. R., Mehta, P. P., Jontes, J., Benfenati, F., Wilson, C. W. & Montecucco, C. (1993a). Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds. FEBS Lett 335, 99-103.
30. Schiavo, G., Rossetto, O., Catsicas, S., de Laureto, P. P., DasGupta, B. R. & Montecucco, C. (1993b). Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E. J Biol Chem 268, 23784-23787.
31. Schmidt, J. J. & Bostian, K. A. (1995). Proteolysis of synthetic peptides by type A botulinum neurotoxin. J Protein Chem 14, 703-708.
32. Sesardic, D., McLellan, K., Ekong, T. A. N. & Gaines Das, R. (1996). Refinement and validation of an alternative bioassay for potency testing of therapeutic botulinum type A toxin. Pharmacol Toxicol 78, 283-288.
33. Shone, C. C. & Roberts, A. K. (1994). Peptide substrate specificity and properties of the zinc-endopeptidase activity of botulinum type B neurotoxin. Eur J Biochem 225, 263-270.
34. Shone, C. C., Wilton-Smith, P., Appleton, N., Hambleton, P., Modi, N., Gatley, S. & Melling, J. (1985). Monoclonal antibody-based immunoassay for type A Clostridium botulinum toxin is comparable to the mouse bioassay. Appl Environ Microbiol 50, 63-67.
35. Simpson, L. L. (1981). The origin, structure and pharmacological activity of botulinum toxin. Pharmacol Rev 33, 155-188.
36. Singh, B. R., Lopes, T. & Silvia, M. A. (1996). Immunochemical characterization of type A botulinum neurotoxin in its purified and complexed forms. Toxicon 34, 267-275.
37. Soleilhac, J.-M., Cornille, F., Martin, L., Lenoir, C., Fournie-Zaluski, M.-C. & Roques, B. P. (1996). A sensitive and rapid fluorescence-based assay for determination of tetanus toxin peptidase activity. Anal Biochem 241, 120-127.
38. Söllner, T., Whiteheart, S. W., Brunner, M., Erjument-Bromage, H., Geromanos, S., Tempst, P. & Rothman, J. E. (1993). SNAP receptors implicated in vesicle targeting and fusion. Nature 362, 318-324.
39. Towbin, H., Staehelin, T. & Gordon, J. (1979). Electrophoretic transfer from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76, 4350-4354.
40. Wictome, M., Rossetto, O., Montecucco, C. & Shone, C. C. (1996). Substrate residues N-terminal to the cleavage site of botulinum type B neurotoxin play a role in determining the specificity of its endopeptidase activity. FEBS Lett 386, 133-136.
41. Williamson, L. C., Halpern, J. L., Montecucco, C., Brown, J. E. & Neale, E. A. (1996). Clostridial neurotoxins and substrate proteolysis in intact neurones: Botulinum neurotoxin C acts on synaptosomal-associated protein of 25 kDa. J Biol Chem 271, 7694-7699.